Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

The Risk of Depression in a Large Huntington Disease Population Compared With Controls: Analysis of the Enroll-HD Registry Data

Author:Reshef, Shoshana   Smith, Gerald   Harari, Ofir   Gordon, Mark   Ribalov, Rinat   Lengil, Tamar   Leo, Sam   Willock, Rosa   Zurita, Jose   Furr-Stimming, Erin   Sung, Victor   

Session Name:P1: Movement Disorders: Huntington's Disease and Chorea 1  

Topic:Movement Disorders  

Program Number:P1.012  

Author Institution:Teva Branded Pharmaceutical Products R&D, Inc., Epidemiology and Global Health Economics and Outcomes Research, Parsippany, NJ  Cytel, Vancouver, BC, Canada  Teva Branded Pharmaceutical Products R&D, Inc., Specialty Clinical Development, West Chester, PA  Teva Pharmaceutical Industries Ltd., Global Health Economics and Outcomes Research, Tel Aviv, Israel  Teva Pharmaceutical Industries Ltd., Global Medical Affairs, Tel Aviv, Israel  Teva Branded Pharmaceutical Products R&D, Inc., Global Health Economics and Outcomes Research, Parsippany, NJ  HCD Economics Ltd., Daresbury, United Kingdom  HCD Economics Ltd., Cheshire, United Kingdom  UTHealth, McGovern Medical School, Houston, TX  University of Alabama At Birmingham, Birmingham, AL  

Melatonin for Huntington Disease (HD) Gene Carriers with HD-Related Sleep Disturbance - a Pilot Study

Author:Patino Murillas, Jorge   Zadegan, Shayan   Pessoa Rocha, Natalia   Karagas, Nicholas   Tanigaki, Will   Duncan, Brittany   Furr-Stimming, Erin   

Session Name:P1: Movement Disorders: Huntington's Disease and Chorea 1  

Topic:Movement Disorders  

Program Number:P1.013  

Author Institution:The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX  UW- Neurology Residency, Seattle, WA  Houston Methodist, Houston, TX  

Baseline Characteristics and Treatment Patterns of a Global Huntington Disease Population Stratified by Chorea Severity

Author:Sung, Victor   Furr-Stimming, Erin   Reshef, Shoshana   Willock, Rosa   Ribalov, Rinat   Brighton, Sarah   Leo, Sam   

Session Name:P2: Movement Disorders: Huntington's Disease and Chorea 2  

Topic:Movement Disorders  

Program Number:P2.011  

Author Institution:University of Alabama At Birmingham, Birmingham, AL  University of Texas Health Science Center-Houston, Houston, TX  Teva Branded Pharmaceutical Products R&D, Inc., Parsippany, NJ  HCD Economics, Daresbury, United Kingdom  Teva Pharmaceutical Industries Ltd., Tel Aviv, Israel  HCD Economics, Macclesfield, United Kingdom  

Nivolumab-induced Central Nervous System (CNS) Vasculitis Brought on by a Steroid Taper

Author:Karbhari, Nishika   Galindo Mendez, Brahyan   Robbins, Nathaniel   

Session Name:P12: Neuro-oncology: Neurologic Complications of Cancer  

Topic:Neuro-oncology  

Program Number:P12.003  

Author Institution:Dartmouth-Hitchcock, Lebanon , NH  

Long-Term Quality of Life in Patients With Focal Seizures Treated With ESL: Pooled Analysis From 3 Phase III Open-Label Extension Studies

Author:Cantu, David   Krishnaiengar, Suparna   Thomases, Daniel   Mehta, Darshan   Hall, Diane   Zhang, Yi   Gama, Helena   Pereira, Ana   Grinnell, Todd   

Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P11.009  

Author Institution:Sunovion Pharmaceuticals Inc. , Fort Lee, NJ  University of Florida, Jacksonville, FL  Sunovion Pharmaceuticals Inc. , Battle Ground, WA  Sunovion Pharmaceuticals Inc. , Marlborough, MA  Bial-Portela & C S.A., Coronado (S. Romão e S. Mamede), Portugal